Drug Profile


Alternative Names: Betamethasone/methocarbamol/indometacin; Indometacin/betamethasone/methocarbamol; Methocarbamol/indometacin/betamethasone

Latest Information Update: 14 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Iroko Pharmaceuticals
  • Class Analgesics; Anti-inflammatories; Antiallergics; Antirheumatics; Corticosteroids; Fluorinated steroids; Indoles; Muscle relaxants; Nonsteroidal anti-inflammatories; Pregnadienetriols
  • Mechanism of Action Cyclooxygenase inhibitors; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Pain

Most Recent Events

  • 14 Aug 2015 No recent reports on development identified - Phase-III for Pain in USA (unspecified route)
  • 06 May 2011 Phase-III clinical trials in Pain in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top